Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex

Nucleic Acids Research

Volumn 29, Issue 10, 2001, Pages 2034-2040

  Hofr, Ctirad ^b   Farrell, Nicholas ^a   Brabec, Viktor ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOUBLE STRANDED DNA; HIGH MOBILITY GROUP PROTEIN; PLATINUM COMPLEX;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA DENATURATION; DNA MODIFICATION; DNA STRAND; DNA STRUCTURE; DRUG DNA BINDING; DRUG EFFICACY; DRUG STRUCTURE; ENERGY TRANSFER; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; SPECTROPHOTOMETRY; THERMODYNAMICS; THERMOSTABILITY;

EID: 0035873558     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.10.2034     Document Type: Article

References (36)

1. Rosenberg, B. (1999) Platinum complexes for the treatment of cancer: why the search goes on? In Lippert, B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 3-30.
2. O'Dwyer, P.J., Stevenson, J.P. and Johnson, S.W. (1999) Clinical status of cisplatin, carboplatin and other platinum-based antitumor drugs. In Lippert, B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 31-72.
3. Reedijk, J. (1996) Improved understanding in platinum antitumour chemistry. Chem. Commun., 801-806.
4. Lepre, C.A. and Lippard, S.J. (1990) Interaction of platinum antitumor compounds with DNA. Nucleic Acids Mol. Biol., 4, 9-38.
5. Johnson, N.P., Butour, J.-L., Villani, G., Wimmer, F.L., Defais, M., Pierson, V. and Brabec, V. (1989) Metal antitumor compounds: the mechanism of action of platinum complexes. Prog. Clin. Biochem. Med., 10, 1-24.
6. Comess, K.M., Burstyn, J.N., Essigmann, J.M. and Lippard, S.J. (1992) Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry, 31, 3975-3990.
7. Eastman, A. (1999) The mechanism of action of cisplatin: from adducts to apoptosis. In Lippert, B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 111-134.
8. Jamieson, E.R. and Lippard, S.J. (1999) Structure, recognition and processing of cisplatin-DNA adducts. Chem. Rev., 99, 2467-2498.
9. Zamble, D.B. and Lippard, S.J. (1999) The response of cellular proteins to cisplatin-damaged DNA. In Lippert, B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 73-110.
10. Farrell, N. (2000) Polynuclear charged platinum compounds as a new class of anticancer agents - toward a new paradigm. In Farrell, N.P. and Kelland, L.R. (eds), Platinum-based Drugs in Cancer Therapy. Humana Press, Totowa, NJ, pp. 321-338.
11. Farrell, N., Qu, Y., Bierbach, U., Valsecchi, M. and Menta, E. (1999) Structure-activity relationship within di-and trinuclear platinum phase I clinical agents. In Lippert, B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zurich, Switzerland, pp. 479-496.
12. Farrell, N., Appleton, T.G., Qu, Y., Roberts, J.D., Fontes, A.P.S., Skov, K.A., Wu, P. and Zou, Y. (1995) Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry, 34, 15480-15486.
13. Zaludova, R., Zakovska, A., Kasparkova, J., Balcarova, Z., Kleinwachter, V., Vrana, O., Farrell, N. and Brabec, V. (1997) DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. Eur. J. Biochem., 246, 508-517.
14. Kasparkova, J., Mellish, K.J., Qu, Y., Brabec, V. and Farrell, N. (1996) Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Biochemistry, 35, 16705-16713.
15. Fichtinger-Schepman, A.M.J., Van der Veer, J.L., Den Hartog, J.H.J., Lohman, P.H.M. and Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification and quantitation. Biochemistry, 24, 707-713.
16. Eastman, A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther., 34, 155-166.
17. +. Biophys. Chem., 35, 179-188.
18. Takahara, P.M., Frederick, C.A. and Lippard, S.J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J. Am. Chem. Soc., 118, 12309-12321.
19. Gelasco, A. and Lippard, S.J. (1998) NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) adduct d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry, 37, 9230-9239.
20. Ohndorf, U.M, Rould, M.A., He, Q., Pabo, C.O. and Lippard, S.J. (1999) Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature, 399, 708-712.
21. Pilch, D.S., Plum, G.E. and Breslauer, K.J. (1995) The thermodynamics of DNA structures that contain lesions or guanine tetrads. Curr. Opin. Struct. Biol., 5, 334-342.
22. Plum, G.E., Grollman, A.P., Johnson, F. and Breslauer, K.J. (1995) Influence of the oxidatively damaged adduct 8-oxodeoxyguanosine on the conformation, energetics and thermodynamic stability of a DNA duplex. Biochemistry, 34, 16148-16160.
23. Poklar, N., Pilch, D.S., Lippard, S.J., Redding, E.A., Dunham, S.U. and Breslauer, K.J. (1996) Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability and energetics of a 20-mer DNA duplex. Proc. Natl Acad. Sci. USA, 93, 7606-7611.
24. Pilch, D.S., Dunham, S.U., Jamieson, E.R., Lippard, S.J. and Breslauer, K.J. (2000) DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link and the conformational and thermodynamic properties of duplex DNA. J. Mol. Biol., 296, 803-812.
25. Farrell, N., Qu, Y., Feng, L. and Van Houten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry, 29, 9522-9531.
26. Brabec, V., Reedijk, J. and Leng, M. (1992) Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry, 31, 12397-12402.
27. Brabec, V. and Leng, M. (1993) DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl Acad. Sci. USA, 90, 5345-5349.
28. Kasparkova, J., Farrell, N. and Brabec, V. (2000) Sequence specificity, conformation and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. J. Biol. Chem., 275, 15789-15798.
29. Haynie, D.T. (1998) Quantitative analysis of differential scanning calorimetric data. In Ladbury, J.E. and Chowdhry, B.Z. (eds), Biocalorimetry. Applications of Calorimetry in the Biological Sciences. John Wiley & Sons, Chichester, UK, pp. 183-205.
30. Hofr, C. and Brabec, V. (2001) Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. J. Biol. Chem., 276, 9655-9661.
31. Malina, J., Hofr, C., Maresca, L., Natile, G. and Brabec, V. (2000) DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands. Biophys. J., 78, 2008-2021.
32. Bailly, C., Gentle, D., Hamy, F., Purcell, M. and Waring, M.J. (1994) Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin. Biochem. J., 300, 165-173.
33. Breslauer, K.J., Frank, R., Blocker, H. and Marky, L.A. (1986) Predicting DNA duplex stability from the base sequence. Proc. Natl Acad. Sci. USA, 83, 3746-3750.
34. Dunham, S.U. and Lippard, S.J. (1997) DNA sequence context and protein composition modulate HMG-domain protein recognition of ciplatin-modified DNA. Biochemistry, 36, 11428-11436.
35. Kasparkova, J. and Brabec, V. (1995) Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. Biochemistry, 34, 12379-12387.
36. Brabec, V. (2000) Chemistry and structural biology of 1,2-interstrand adducts of cisplatin. In Kelland, L.R. and Farrell, N.P. (eds), Platinum-based Drugs in Cancer Therapy. Humana Press, Totowa, NJ, pp. 37-61.